Mezzion Pharma Co.,Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was KRW 977.89 million compared to net income of KRW 2,157.28 million a year ago. Basic loss per share from continuing operations was KRW 33 compared to basic earnings per share from continuing operations of KRW 81 a year ago. Diluted loss per share from continuing operations was KRW 33 compared to diluted earnings per share from continuing operations of KRW 69 a year ago. Basic loss per share was KRW 33 compared to basic earnings per share of KRW 81 a year ago.
For the nine months, net loss was KRW 6,383.5 million compared to KRW 18,187.33 million a year ago. Basic loss per share from continuing operations was KRW 230 compared to KRW 681 a year ago. Diluted loss per share from continuing operations was KRW 230 compared to KRW 681 a year ago. Basic loss per share was KRW 230 compared to KRW 681 a year ago.